¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21
±³À°ÀÏÀÚ : 2020-03-21
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : ILD School 2020
ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : °£Áú¼ºÆóÁúȯ(ILD)¿¬±¸È¸
´ã´çÀÚ : ±è½ÃÀ±
¿¬¶ôó : 02-575-3825  
À̸ÞÀÏ : katrd@hanmail.net      
±³À°Á¾·ù : ³»°ú, °áÇÙ°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í »çÀüµî·Ï : 10,000¿ø ÇöÀåµî·Ï : 20,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 14:10~14:40 Idiopathic Pulmonary Fibrosis: Current Management and Future Perspectives  ÃÖ¼±¹Ì(¼­¿ïÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 14:40~15:10 An Evolving ILD : Pleuroparenchymal Fibroelastosis  ÀÌÀçÇÏ(ÀÎÁ¦ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 15:10~15:40 Diagnostic Approach to Diffuse Cystic Lung Disease: Radiologists¡¯ Perspectives  Ã¤ÀºÁø(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 16:10~16:40 Progressive Fibrosing-ILD: Concept and Pharmacologic Management  ¼ÛÁø¿ì(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 16:40~17:10 Systemic Sclerosis Associated ILD: where do we stand  ÀÌÁ¾¹Î(°¡Å縯ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 17:10~17:40 Chronic Hypersensitivity Pneumonitis: the New Diagnostic Criteria and Treatment  À¯È«¼®(¼º±Õ°üÀÇ´ë ³»°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" »ï¼º¼­¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æºÏ´ëÇб³º´¿ø ¿µ³² ³»°ú°è ½ÅÀåÀÌ½Ä ¿¬±¸È¸ Á¦25Â÷ ÇмúÁý´ãȸ : 2020-03-21
´ÙÀ½±Û 2020 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2020-03-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20131 ´ëÀü ´ëÇѽŰæ¿Ü°úÇÐȸ ´ëÀüÃæûÁöȸ Á¤±âÇмú´ëȸ : 2024-04-05 0 80 2024-03-20
20130 ºÎ»ê 2024 Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ Ãá°èÇмú´ëȸ (SoLA 2024) 1ÀÏÂ÷ : 2024-04-05 0 96 2024-03-20
20129 ´ëÀü ´ëÇÑÇǺÎÁø±Õ ¹× °¨¿°ÇÐȸ ¼øȸ¿¬¼ö±³À° : 2024-04-05 0 95 2024-03-20
20128 ÀÎõ ´ëÇѼÒÈ­±â±â´É¼ºÁúȯ¹×¿îµ¿ÇÐȸ APNM 2024 (11th Asian Postgraduate Course on Neurogastroenterology and Motility in conjunction with the 35th Annual Conference of the Korean Society of Neurogastroenterology and Motility) (1ÀÏÂ÷) : 2024-04-05 0 109 2024-03-20
20127 ¼­¿ï ´ëÇÑ°£¾ÏÇÐȸ Á¦18Â÷ Á¤±âÇмú´ëȸ-Liver Cancer without Borders : 2024-04-05 0 115 2024-03-20
20126 ¼­¿ï 2024 ´ëÇÑ»ý¹°Á¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-04-05 0 64 2024-03-20
20125 ¼­¿ï ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ 2024³â 4¿ù Áý´ãȸ : 2024-04-04 0 90 2024-03-20
20124 ¼­¿ï °­³²¼¼ºê¶õ½º ¾È°ú Áö¿ªÀÇ»çÁý´ãȸ( °©»ó¼±¾Èº´Áõ) : 2024-04-02 0 89 2024-03-20
20123 ´ëÀü ´ëÇѼҾƳ»ºÐºñÇÐȸ ÁߺÎÁöȸ Áý´ãȸ 2024-1Â÷(°¡¼ºÀú¾Ëµµ½ºÅ×·ÐÇ÷Áõ) : 2024-04-02 0 106 2024-03-20
20122 °­¿ø 2024 Ãáõ½ÃÀÇ»çȸ 4¿ù ¿¬¼ö°­ÁÂ(½ºÆ®·¹½º, Æó°æ ÈÄ È£¸£¸ó Ä¡·á) : 2024-04-01 0 116 2024-03-20
20121 ¼­¿ï Á¦ 26ȸ ´ëÇÑÇǺΰúÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-03-31 0 127 2024-03-20
20120 ´ëÀü ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Á¦57Â÷ Çмú´ëȸ (3ÀÏÂ÷) : 2024-03-31 0 190 2024-03-19
20119 ¼­¿ï Á¦42ȸ ´ëÇѹ̿ë¿Ü°ú & ¹Ì¿ëÀÇÇÐÇмú´ëȸ : 2024-03-31 0 106 2024-03-19
20118 ¼­¿ï 2024³âµµ Á¦ 29Â÷ ´ëÇÑÁ¤À§±â´É½Å°æ¿Ü°úÇÐȸ Á¤±âÇмú´ëȸ : 2024-03-30 0 102 2024-03-19
20117 ¼­¿ï ´ëÇѳú½Å°æÀçÈ°ÇÐȸ Á¦18Â÷ Ãá°èÇмú´ëȸ : 2024-03-30 0 109 2024-03-19
71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷